Loading...
Explore Gaudium IVF IPO details, including IPO dates, financial statements, valuation, peer comparison and more.
Gaudium IVF and Women Health Limited, incorporated in March 2015, is a company providing In Vitro Fertilization (IVF) treatments and specialized fertility services across India.
Core Business: In Vitro Fertilization (IVF) treatments and related fertility services.
Main Products/Services: In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), ovulation induction, comprehensive gynaecological care for PCOD/PCOS and endometriosis, and high-risk pregnancy management.
Industry Focus: Assisted Reproductive Technology (ART) and Women's Health.
Key Highlights:
Discover essential information crucial for understanding an IPO, including the Price Band, Fresh Issue, Offer For Sale, Total IPO Size and more. Explore these key details to gain insight into the company's public offering.
| Fields | Details |
|---|---|
| IPO Dates | 20 Feb - 24 Feb 2026 |
| IPO Price Band | ₹75 - ₹79 per share |
| Fresh Issue | 90.00 Cr |
| Offer For Sale | 75.00 Cr |
| Total IPO Size | 165.00 Cr |
| Face Value | 5 |
| Listing On | BSE, NSE |
Explore important dates like IPO opening, closing, listing and others, outlining the journey of the Public Offering. This will help you grasp the entire IPO journey effortlessly.
| Event | Date |
|---|---|
| IPO Opening Date | 20 Feb 2026 |
| IPO Closing Date | 24 Feb 2026 |
| Basis Of Allotment | 25 Feb 2026 |
| Refunds | 25 Feb 2026 |
| Demat Transfer | 26 Feb 2026 |
| IPO Listing Date | 27 Feb 2026 |
Explore a comprehensive financial data table showcasing key metrics including revenue, expenses, net income, and others. Gain valuable insights about the company's financial performance at a glance, facilitating informed decision-making and strategic planning for subscribing to the IPO.
| Period Ended | 31 Mar 2023 | 31 Mar 2024 | 31 Mar 2025 | 30 Sep 2025 |
|---|---|---|---|---|
| Assets | 36.63 | 51.01 | 88.51 | 106.62 |
| Total Income | 44.26 | 48.15 | 70.96 | 49.75 |
| Profit After Tax | 13.53 | 10.32 | 19.13 | 12.51 |
| EBITDA | 20.07 | 19.27 | 28.63 | 18.95 |
| NET Worth | 22.73 | 26.99 | 46.30 | 58.85 |
| Reserves and Surplus | 21.74 | 26.00 | 15.60 | 28.16 |
| Total Borrowing | 9.78 | 15.73 | 18.93 | 22.51 |
* NPM represents the net profit margin, calculated as a percentage. All other figures are presented in crore (₹cr)
Compare key financial metrics with industry peers to gain valuable insights into the company's performance compared to its competitors.
| Name | P/E | EPS | RoNW | NAV |
|---|---|---|---|---|
| Gaudium IVF and Women Health | 25.32 | 3.12 | 41.71% | 7.54 |
| Inspire IVF Public Company | 11.43 | 0.17 | 3.97% | 4.34 |
| Progyny Inc. | 41.56 | 50.52 | 12.9% | 394.2 |
* Revenue in (₹cr), RoNW in (%), EPS, NAV in (₹). P/E ratio is based on the highest price from the IPO price band.
| Investor Type | Shares Offered |
|---|---|
| Qualified Institutional Buyer (QIB) | Not more than 50% of the Net Issue |
| Non-Institutional Investor (NII/HNI) | Not less than 15% of the Net Issue |
| Retail Individual Investor (RII) | Not less than 35% of the Net Issue |
| Investor Type | Subscribed |
|---|---|
| Qualified Institutional Buyer (QIB) | 1.62 |
| Non-Institutional Investor (NII/HNI) | 14.05 |
| Retail Individual Investor (RII) | 7.6 |
| Total | 7.27 |
* All figures represent multiples of the subscription. Check subscriptions for other ongoing issues here.
MUFG Intime India Private Limited (Formerly known as Link Intime India Private Limited)
Phone: + 91 810 811 4949
Email: ipo.helpdesk@linkintime.co.in
Website: https://linkintime.co.in/
Gaudium IVF & Women Health Ltd.
B1/51,
Janak Puri,
B-1,
New Delhi, New Delhi –110058
Website:https://www.gaudiumivfcentre.com/
Phone:011-4885 8585
Email:compliance@gaudiumivfcentre.com